Literature DB >> 16864052

T-cell receptor Valpha spectratype analysis of a CD4-mediated T-cell response against minor histocompatibility antigens involved in severe graft-versus-host disease.

Christine G DiRienzo1, George F Murphy, Stephen C Jones, Robert Korngold, Thea M Friedman.   

Abstract

Although CD4(+) T cells can have an important role in mediating lethal graft-versus-host disease (GVHD) directed to multiple minor histocompatibility antigens (miHA) after bone marrow transplantation, their precise characterization and effector function remains elusive. In this regard, T cell receptor (TCR) Vbeta spectratype analysis has been a powerful tool for identifying donor CD4(+) T cell populations expanding to host miHA after bone marrow transplantation in the major histocompatibility complex-matched C57BL/6 (B6) --> C.B10-H2(b) (BALB.B) model of lethal GVHD. Removal of all of the Vbeta(+) T cell families containing these responding cells from the donor inoculum has proven to be an effective means of preventing the development of GVHD. Previous studies have also found that of the 11 miHA-responsive B6 CD4(+) Vbeta(+) T cell families, transplantation of Vbeta2(+) and Vbeta11(+) T cells together into lethally irradiated BALB.B mice appeared to be primarily responsible for the severity of resultant GVHD. Further focusing on these critical CD4 responses, in this study we demonstrate that B6 CD4(+)Vbeta11(+) T cells alone can induce lethal GVHD in BALB.B recipients. In addition, immunohistochemical staining of host lingual and intestinal epithelial tissues supported the capacity of Vbeta11(+) T cells to infiltrate typical GVHD-associated target areas. To further characterize the specific CD4(+)Vbeta11(+) T cells involved in this anti-miHA response, TCR Valpha spectratype analysis was performed and indicated that 6 Valpha chains were used by this reactive population. These results provide further evidence that a restricted repertoire of T cell specificities, presumably recognizing a correspondingly low number of miHA, is sufficient for the induction of severe GVHD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16864052      PMCID: PMC2602873          DOI: 10.1016/j.bbmt.2006.05.002

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  38 in total

1.  The crystal structure of a T cell receptor in complex with peptide and MHC class II.

Authors:  E L Reinherz; K Tan; L Tang; P Kern; J Liu; Y Xiong; R E Hussey; A Smolyar; B Hare; R Zhang; A Joachimiak; H C Chang; G Wagner; J Wang
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

Review 2.  Pathophysiologic mechanisms of acute graft-vs.-host disease.

Authors:  J L Ferrara; R Levy; N J Chao
Journal:  Biol Blood Marrow Transplant       Date:  1999       Impact factor: 5.742

Review 3.  Preferential expression of TCR V alpha regions in CD4/CD8 subsets: class discrimination or co-receptor recognition?

Authors:  B C Sim; D Lo; N R Gascoigne
Journal:  Immunol Today       Date:  1998-06

4.  MHC class I-restricted epitope spreading in the context of tumor rejection following vaccination with a single immunodominant CTL epitope.

Authors:  K el-Shami; B Tirosh; E Bar-Haim; L Carmon; E Vadai; M Fridkin; M Feldman; L Eisenbach
Journal:  Eur J Immunol       Date:  1999-10       Impact factor: 5.532

5.  Vbeta spectratype analysis reveals heterogeneity of CD4+ T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: correlations with epithelial tissue infiltrate.

Authors:  T M Friedman; D Statton; S C Jones; M A Berger; G F Murphy; R Korngold
Journal:  Biol Blood Marrow Transplant       Date:  2001       Impact factor: 5.742

6.  Restricted usage of T-cell receptor alpha-chain variable region (TCRAV) and T-cell receptor beta-chain variable region (TCRBV) repertoires after human allogeneic haematopoietic transplantation.

Authors:  T Matsutani; T Yoshioka; Y Tsuruta; S Iwagami; T Toyosaki-Maeda; T Horiuchi; A B Miura; A Watanabe; G Takada; R Suzuki; M Hirokawa
Journal:  Br J Haematol       Date:  2000-06       Impact factor: 6.998

7.  Infiltrating T cells during liver graft-versus-host disease show a restricted T-cell repertoire.

Authors:  D A Margolis; J T Casper; A D Segura; T Janczak; L McOlash; B Fisher; K Miller; J Gorski
Journal:  Biol Blood Marrow Transplant       Date:  2000       Impact factor: 5.742

8.  Cross-protective murine graft-versus-leukemia responses to phenotypically distinct myeloid leukemia lines.

Authors:  A E Patterson; R Korngold
Journal:  Biol Blood Marrow Transplant       Date:  2000       Impact factor: 5.742

Review 9.  Leukocyte migration and graft-versus-host disease.

Authors:  Christian A Wysocki; Angela Panoskaltsis-Mortari; Bruce R Blazar; Jonathan S Serody
Journal:  Blood       Date:  2005-02-08       Impact factor: 22.113

10.  Repertoire analysis of CD8+ T cell responses to minor histocompatibility antigens involved in graft-versus-host disease.

Authors:  T M Friedman; M Gilbert; C Briggs; R Korngold
Journal:  J Immunol       Date:  1998-07-01       Impact factor: 5.422

View more
  8 in total

1.  Induction of acute GVHD by sex-mismatched H-Y antigens in the absence of functional radiosensitive host hematopoietic-derived antigen-presenting cells.

Authors:  Tomomi Toubai; Isao Tawara; Yaping Sun; Chen Liu; Evelyn Nieves; Rebecca Evers; Thea Friedman; Robert Korngold; Pavan Reddy
Journal:  Blood       Date:  2011-11-18       Impact factor: 22.113

2.  T-cell receptor V(alpha) usage by effector CD4+Vbeta11+ T cells mediating graft-versus-host disease directed to minor histocompatibility antigens.

Authors:  Christine G DiRienzo; George F Murphy; Thea M Friedman; Robert Korngold
Journal:  Biol Blood Marrow Transplant       Date:  2007-03       Impact factor: 5.742

3.  Uneven colonization of the lymphoid periphery by T cells that undergo early TCR{alpha} rearrangements.

Authors:  Deborah W Hendricks; Pamela J Fink
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

4.  Overlap between in vitro donor antihost and in vivo posttransplantation TCR Vbeta use: a new paradigm for designer allogeneic blood and marrow transplantation.

Authors:  Thea M Friedman; Kira Goldgirsh; Stephanie A Berger; Jenny Zilberberg; Joanne Filicko-O'Hara; Neal Flomenberg; Michele Donato; Scott D Rowley; Robert Korngold
Journal:  Blood       Date:  2008-06-09       Impact factor: 22.113

5.  Breakdown of immune privilege and spontaneous autoimmunity in mice expressing a transgenic T cell receptor specific for a retinal autoantigen.

Authors:  Reiko Horai; Phyllis B Silver; Jun Chen; Rajeev K Agarwal; Wai Po Chong; Yingyos Jittayasothorn; Mary J Mattapallil; Sonia Nguyen; Kannan Natarajan; Rafael Villasmil; Peng Wang; Zaruhi Karabekian; Simon D Lytton; Chi-Chao Chan; Rachel R Caspi
Journal:  J Autoimmun       Date:  2013-06-28       Impact factor: 7.094

6.  Recipient-specific T-cell repertoire reconstitution in the gut following murine hematopoietic cell transplant.

Authors:  Pingping Zheng; John Tamaresis; Govindarajan Thangavelu; Liwen Xu; Xiaoqing You; Bruce R Blazar; Robert S Negrin; James L Zehnder; Bettina P Iliopoulou; Everett H Meyer
Journal:  Blood Adv       Date:  2020-09-08

Review 7.  [Cutaneous graft-versus-host disease].

Authors:  A Cho; U Just; R Knobler
Journal:  Hautarzt       Date:  2018-02       Impact factor: 0.751

Review 8.  Cutaneous Graft-Versus-Host Disease: Diagnosis and Treatment.

Authors:  Karla Strong Rodrigues; Carla Oliveira-Ribeiro; Silvia de Abreu Fiuza Gomes; Robert Knobler
Journal:  Am J Clin Dermatol       Date:  2018-02       Impact factor: 7.403

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.